⚕️ Educational information only — not medical advice. Read the full disclaimer

Reactive Arthritis: Arthritis After an Infection

Reactive arthritis is the clearest proof that an infection can set off arthritis. A few days to several weeks after a bout of food poisoning or a sexually transmitted infection, a knee, ankle or heel swells up — yet the joint itself contains no live, growing germs. The immune response to the earlier infection has spilled over into the joints, tendon attachments and sometimes the eyes. Most people recover, but a minority develop longer-lasting disease. This page covers which infections trigger it and how often, what it looks like, why the old name "Reiter's syndrome" was dropped, how doctors rule out a joint infection, how long it tends to last, and the treatment and prevention options, with honest evidence grading throughout.

Important: This page is general educational information, not medical advice. A swollen joint after an infection must be assessed by a qualified clinician, because a joint infection (septic arthritis) can look similar and is an emergency. Always consult a healthcare professional before starting, stopping or changing any medication, supplement or exercise program.

Key takeaways

  • Reactive arthritis is a sterile inflammatory arthritis that follows an infection elsewhere — usually the gut or urogenital tract — and belongs to the spondyloarthritis family. Strong
  • Classic triggers are Salmonella, Shigella, Campylobacter, Yersinia and Chlamydia trachomatis; C. difficile is a rarer cause. Strong
  • After a gut infection, roughly 1–12% of people develop it, depending on the germ and how carefully cases are counted. Strong
  • Typical pattern: asymmetric arthritis of a few lower-limb joints, heel or tendon pain (enthesitis), "sausage" toes, sometimes red eyes, urethritis or skin changes. Most people never have the full "classic triad". Strong
  • HLA-B27 does not decide whether reactive arthritis occurs, but it is linked to more severe and chronic disease. Strong
  • It usually settles within months; an estimated 15–20% develop chronic or relapsing problems. Emerging (exact figure)
  • Arthritis after COVID-19 has been reported as reactive arthritis, but evidence is limited to case reports and series. Emerging

What reactive arthritis is Strong

Reactive arthritis (ReA) is defined as a sterile inflammatory arthritis that develops as a sequel to an infection somewhere else in the body, most often in the gastrointestinal or urogenital tract.1 It is classified as one of the spondyloarthritides — the family that also includes ankylosing spondylitis, psoriatic arthritis and the arthritis of inflammatory bowel disease.23 Like its relatives, it favors the entheses (where tendons and ligaments attach to bone), can involve the spine and eyes, and has links to the gene variant HLA-B27. Unlike rheumatoid arthritis, blood tests for rheumatoid factor and anti-CCP are typically negative — one reason the group is sometimes called "seronegative" arthritis.

Mechanism: infection elsewhere, inflammation in the joint

The triggering bacteria are mostly ones that can live inside cells. Bacterial fragments and antigens — and, for Chlamydia, organisms in a persistent, metabolically active but non-dividing state — have been found in the joint lining, even though standard cultures of joint fluid are negative.2327 The immune system's response to this material, shaped by the person's genes, is thought to drive the arthritis. Exactly why only some infected people develop it is still not fully understood.12

Reactive arthritis is also the best-established example of the broader idea, discussed on root causes, that infections can trigger inflammatory arthritis. That page also covers more speculative ideas — such as the proposed Proteus mirabilis link to rheumatoid arthritis, which remains Contested — and it is worth keeping the two apart: the evidence for reactive arthritis is far stronger.

Triggering infections Strong (classic triggers) Emerging (rarer and newer triggers)

The American College of Rheumatology lists Chlamydia trachomatis and the bowel infections Clostridioides (Clostridium) difficile, Campylobacter, Salmonella, Shigella and Yersinia as the most common triggers.25 Importantly, the triggering infection can be mild or even unnoticed: in a U.S. sexually transmitted infection clinic study, the genital infection was asymptomatic in 78% of people who had reactive arthritis features.11

Infections linked to reactive arthritis
InfectionUsual sourceNotesEvidence
Campylobacter (C. jejuni, C. coli)Undercooked poultry, unpasteurized milk, contaminated waterHighest population incidence in U.S. FoodNet data; usually mild arthritis47Strong
SalmonellaEggs, poultry, meat, produceClassic outbreak trigger; long-term follow-up data exist815Strong
Shigella (S. sonnei, S. flexneri, S. dysenteriae)Person-to-person spread, contaminated food or waterAll three species can trigger it9Strong
YersiniaUndercooked pork, contaminated produceOne outbreak study described a severe, often prolonged picture10Strong
Chlamydia trachomatisSexually transmittedThe main cause of post-venereal reactive arthritis; often asymptomatic1123Strong
C. difficileUsually after antibiotic useUncommon; about 40 cases had been reported by 200812Emerging
SARS-CoV-2 (COVID-19)RespiratoryCase reports and series of arthritis after COVID-19 classified as reactive arthritis1314Emerging

About post-COVID arthritis: a 2023 systematic review pooled 95 published patients who developed arthritis after COVID-19, noting that there is no agreed way to classify these cases and that labels reflected each author's judgment.14 A 2022 review concluded that SARS-CoV-2 is "emerging" as a trigger of apparent reactive arthritis and also listed new case-report triggers such as Mycoplasma pneumoniae and Giardia.13 Case reports cannot show how often this happens, or prove cause and effect, so treat this as an open question.

How common is it after an infection? Strong

The honest answer is "it depends on how you count". Because there are no universally agreed diagnostic criteria, estimates vary several-fold between studies.56

13%reported possible ReA within 8 weeks of a culture-confirmed gut infection (U.S. FoodNet)4
7–12%developed ReA after Finnish Campylobacter, Salmonella, Shigella and Yersinia studies78910
~1%weighted mean in a global systematic review (9–12 per 1,000 infections)5
4%of STI-clinic patients with genital infection had objective ReA features11
  • U.S. population data: of 6,379 culture-confirmed Campylobacter, E. coli O157, Salmonella, Shigella and Yersinia infections in Minnesota and Oregon, 13% of those screened reported possible reactive arthritis; 66% of those examined (54 of 82) were confirmed. Risk was higher in women, adults and people with a severe acute illness, and was not associated with antibiotic use or HLA-B27.4
  • After outbreaks: in a Finnish Salmonella Typhimurium outbreak, 8% of responders met criteria for reactive arthritis; the authors concluded that the frequency after various outbreaks is approximately 10%.8 After a Yersinia pseudotuberculosis outbreak, 12% did.10
  • Systematic reviews: one estimated 1–5% after Campylobacter;6 another, using standardized criteria, found weighted means of 9, 12 and 12 cases per 1,000 Campylobacter, Salmonella and Shigella infections.5
  • Long-term joint symptoms: after the Walkerton, Ontario drinking-water outbreak (E. coli O157:H7 and Campylobacter), self-reported arthritis 4.5 years later was 21.6% in people who had severe gastroenteritis versus 15.7% in those who were asymptomatic — a modest excess, with no difference in arthritis prescriptions.24

Across populations, annual incidence estimates range from about 0.6 to 27 per 100,000 people.1 The key reassurance: most people who get these very common infections never develop reactive arthritis.25

Timing: days to weeks later Strong

Joint symptoms typically begin about 1 to 4 weeks after the infection — a Finnish review describes acute arthritis developing within 2–4 weeks, and the NHS gives 1–4 weeks.126 The U.S. FoodNet study counted new symptoms appearing within 8 weeks of the stool culture.4 Because the diarrhea or urinary symptoms have often settled by the time the joints flare — or were never noticed — people frequently do not connect the two. Tell your doctor about any stomach bug, food poisoning, new sexual partner or urinary symptoms in the preceding couple of months.

Classic features Strong

The textbook picture is an asymmetric oligoarthritis — a few joints, not mirrored on both sides — mostly in the large joints of the legs.112 Extra-articular features may accompany it. The old "triad" of arthritis, urethritis and conjunctivitis is the exception, not the rule: most patients do not present with the full triad.3

Features of reactive arthritis
AreaWhat people notice
JointsPain and swelling in knees, ankles or feet, usually a few joints and asymmetric; can be polyarticular725
EnthesesHeel pain (Achilles tendon or sole of the foot); enthesitis was the most frequent finding in the U.S. FoodNet study4
DactylitisA whole toe or finger swells like a "sausage"25
SpineInflammatory low back or buttock pain, worse at night or in the morning; low back pain in 44% of a hospital Salmonella cohort1525
EyesRed, irritated eyes (conjunctivitis); less often painful, light-sensitive eye inflammation (uveitis or iritis), which needs urgent care1215
UrogenitalBurning on urination or discharge (urethritis, cervicitis), sometimes even after a gut trigger1525
Skin, nails and mouthRash on palms or soles (keratoderma blennorrhagicum), circinate balanitis, nail changes, mouth ulcers16
GeneralTiredness, low-grade fever, raised inflammatory markers such as CRP and ESR

The pattern overlaps with psoriatic arthritis (enthesitis, dactylitis, skin changes) and differs from the symmetric small-joint pattern of rheumatoid arthritis; see how other arthritis types compare.

HLA-B27: severity, not destiny Strong

HLA-B27 is often described as if it were required for reactive arthritis. Population studies say otherwise. In the U.S. FoodNet study, risk was not associated with HLA-B27;4 in a Finnish Campylobacter study only 14% of patients with reactive arthritis carried it;7 and in an STI-clinic study, HLA-B27 and related antigens were not associated with occurrence.11 A leading review advises that HLA-B27 should not be used as a diagnostic test for acute reactive arthritis.1

Where HLA-B27 matters is the course. In a Finnish cohort hospitalized with Salmonella arthritis and followed for about 11 years, HLA-B27-positive patients had more inflammation; extra-articular features, sacroiliitis, recurrent or chronic arthritis and iritis occurred only in HLA-B27-positive patients.15 The ACR summarizes it the same way: HLA-B27 carriers may be at higher risk of severe or chronic arthritis, but people who test negative can get reactive arthritis too.25 See the glossary and psoriatic arthritis genetics for more.

Why "Reiter's syndrome" was dropped Strong

For decades the arthritis–urethritis–conjunctivitis combination was called Reiter's syndrome, after the German physician Hans Reiter. Two problems led rheumatologists to abandon the eponym:

  • Reiter's role in Nazi war crimes. Historical work showed that Reiter, a senior health official in the Nazi regime, endorsed some of the most horrific experiments conducted on concentration camp prisoners. Rheumatologists argued he did not deserve eponymous honor.17 In 2007, a letter in Arthritis & Rheumatism formally "retracted" the suggestion, made 65 years earlier, to use the term "Reiter's syndrome", arguing that Reiter's legacy should be condemnation rather than eponymic honor.18
  • It was neither original nor accurate. Similar cases had been described long before Reiter,17 and focusing on the complete triad hampered research because most patients never have all three features.3

"Reactive arthritis" has been the preferred term for decades,1 though you may still see the old name in older articles and some medical records.

Diagnosis & ruling out septic arthritis Strong

There is no single test for reactive arthritis. The diagnosis is mainly clinical: a compatible pattern of arthritis after a plausible infection, plus evidence of that infection where possible, and the exclusion of other causes.12 Investigations a clinician may consider include:

  • Stool tests if diarrhea is ongoing or recent (by the time joints flare, cultures are often negative).
  • Urine or genital swab NAAT tests for Chlamydia trachomatis (and gonorrhea), even without urinary symptoms.1122
  • Blood tests: CRP and ESR (often raised), blood count, kidney function; rheumatoid factor and anti-CCP to look for other conditions; sometimes HLA-B27 for prognosis rather than diagnosis.1 See autoimmune markers.
  • Joint aspiration — drawing fluid from a swollen joint to check for bacteria and crystals. This is how septic arthritis and gout are ruled out.
  • Imaging such as ultrasound or MRI for enthesitis or sacroiliitis in selected cases.
Red flag — septic arthritis: a joint that is infected with bacteria is a medical emergency with high morbidity and mortality, and timely aspiration of the joint is the key step.19 A single hot, very painful joint, especially with fever, chills or feeling unwell, must not be assumed to be reactive arthritis. Disseminated gonorrhea can also cause arthritis with skin lesions and tendon inflammation. Seek same-day care.

Course: how long does it last? Strong (most improve) Emerging (exact chronic rate)

For many people reactive arthritis is a self-limiting illness lasting a few months.2 The NHS says it usually goes away within about six months, though it can last longer, come back, or lead to another long-term arthritis such as ankylosing spondylitis.26 In Finnish outbreak studies, acute arthritis lasted more than six months in 2 of 5 people after Salmonella and in 3 of 4 after Yersinia — small numbers, but a reminder that recovery can be slow.810

Longer-term outcomes reported in studies
StudyFinding
Dermatology review (2008)15–20% of patients may develop severe chronic sequelae16
Campylobacter systematic review (2007)About 5% chronic or relapsing musculoskeletal symptoms; long-term data sparse6
Hospitalized Salmonella arthritis, ~11-year follow-up (1997)Of 50 patients: 20 fully recovered, 10 mild joint symptoms, 11 new acute arthritis, 5 iritis, 8 (16%) chronic spondyloarthritis — all recurrent/chronic disease in HLA-B27-positive patients15

The chronic rate depends heavily on who is studied: hospital cohorts (sicker, often HLA-B27-positive) show more long-term disease than population screening, where acute reactive arthritis is usually mild.715 Long-term outcome data for chlamydia-triggered disease are particularly lacking.1

Treatment overview Strong (NSAIDs, sulfasalazine, treating active chlamydia) Emerging (biologics, long-term antibiotics)

This is an overview to help you understand the options a clinician may discuss — not a treatment plan. Choices depend on how severe and how long-lasting the disease is, your other conditions and your preferences, so talk to your doctor or pharmacist.

How reactive arthritis is typically managed
ApproachWhen it is usedEvidence
NSAIDsFirst line in the early, acute stage25Strong
Corticosteroid joint injectionFor a severely inflamed joint, once infection has been excluded; short oral courses are sometimes used25Strong
DMARDs (e.g. sulfasalazine, methotrexate)Chronic or persistent disease. In a 134-patient VA trial of reactive arthritis not responding to NSAIDs, sulfasalazine response was 62.3% vs 47.7% with placebo2025Strong
TNF-inhibitor biologics (e.g. etanercept, adalimumab)Severe disease not controlled by the above; evidence comes from case series rather than randomized trials225Emerging
Antibiotics for an active infectionAn ongoing chlamydia (or other) infection is treated in its own right, and sexual partners are treated too22Strong
Long-term antibiotics for the arthritisThree months of ciprofloxacin did not help reactive arthritis overall, or after Yersinia or Salmonella.21 A 6-month combination course helped 63% vs 20% on placebo in 42 people with chronic chlamydia-induced disease — promising but small and unreplicated23Contested
Physiotherapy and exerciseMaintaining movement and strength, especially for enthesitis and back involvement26Emerging
Do not start, stop or change medicines on your own. NSAIDs can affect the stomach, kidneys and heart, and DMARDs and biologics need monitoring. Discuss risks, benefits and side effects with your rheumatologist or pharmacist.

Whether giving antibiotics during a gut infection prevents reactive arthritis is unsettled: one Finnish outbreak study found fewer joint symptoms in people who received early antibiotics,8 while the larger U.S. FoodNet study found no association.4 Contested Antibiotics are not routinely needed for many cases of uncomplicated gastroenteritis, so this is a decision for the treating clinician.

Gut health, movement & self-care Emerging

From a holistic perspective, reactive arthritis sits at the meeting point of the gut, the immune system and the joints. The gut and arthritis page explains why the gut–joint link in spondyloarthritis is real, while the popular "leaky gut" story is far less certain. At present there is no good trial evidence that probiotics, special diets or supplements prevent reactive arthritis or shorten it, so treat claims that they do with caution.

  • Rest inflamed joints briefly, then keep moving. Gentle range-of-motion work and gradual strengthening help prevent stiffness and weakness; see exercise during flares vs remission.
  • Heel and tendon pain: supportive footwear and a physiotherapist's advice on loading can help with enthesitis.
  • Recover from the infection: hydration and rest during gastroenteritis, and completing any treatment prescribed for chlamydia.
  • General anti-inflammatory habits — not smoking, good sleep and a whole-food eating pattern — support overall health; see the anti-inflammatory plan.
Dietary & supplement note: Statements here about foods and dietary supplements have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease.

Prevention Strong (preventing the infections)

The only proven way to prevent reactive arthritis is to avoid the infections that trigger it.

Food and water safety

  • Wash hands after the toilet, changing diapers and handling raw meat
  • Cook poultry, meat and eggs thoroughly; avoid unpasteurized milk
  • Keep raw meat away from ready-to-eat food; refrigerate promptly
  • Take care with untreated water, especially when traveling

Sexual health

  • Use condoms with new or casual partners
  • Get tested for chlamydia if at risk — it is often symptomless
  • Make sure partners are tested and treated to avoid re-infection22
  • Tell your clinician about joint, eye or heel symptoms after an STI

When to see a doctor Strong

Seek urgent, same-day medical care if:
  • a joint is hot, red, very painful and swollen, especially with fever, chills or feeling generally unwell — septic arthritis must be excluded;19
  • you have a painful red eye, light sensitivity or blurred vision (possible uveitis);
  • you have bloody diarrhea, signs of dehydration, or are very unwell with a gut infection;
  • you have a prosthetic joint, are immunosuppressed or have diabetes and develop a new swollen joint.

Book a prompt appointment if you:

  • develop joint, heel or back pain within weeks of food poisoning, diarrhea or a sexually transmitted infection — the ACR advises seeing a clinician right away;25
  • have burning urination or discharge (you may need STI testing, and partners may need treatment);
  • still have joint symptoms after several months, or symptoms that keep returning;
  • have inflammatory back pain (worse with rest, better with movement, morning stiffness), which may signal spondyloarthritis.

Frequently asked questions

What is reactive arthritis?

Reactive arthritis is joint, tendon-attachment or eye inflammation that develops a few days to several weeks after an infection elsewhere in the body, most often a gut infection such as Salmonella, Shigella, Campylobacter or Yersinia, or the sexually transmitted infection Chlamydia trachomatis. The joint itself is not infected; the immune response to the earlier infection drives the inflammation. It belongs to the spondyloarthritis family. This is educational information, not medical advice.

How long does reactive arthritis last?

Many people recover within a few months, and the NHS says it usually goes away within about six months. A minority have symptoms for longer, flares that come back, or a chronic spondyloarthritis; reviews estimate that roughly 15–20% may have chronic problems, more often if they carry HLA-B27.

Does HLA-B27 cause reactive arthritis?

No. HLA-B27 is not required and is not a diagnostic test. In a large U.S. population-based study, HLA-B27 did not predict who developed reactive arthritis after a gut infection. It is, however, linked to more severe disease and to a more chronic or relapsing course, including back and eye involvement.

Will antibiotics cure reactive arthritis?

Antibiotics are used to treat an infection that is still active, such as chlamydia, and sexual partners also need treatment. Trials have not shown that long courses of antibiotics help arthritis that followed Salmonella, Yersinia or Campylobacter infection. A small trial of six months of combination antibiotics in chronic chlamydia-induced reactive arthritis was positive but needs confirmation. Treatment decisions belong with your doctor.

Is reactive arthritis contagious?

The arthritis itself is not contagious. The infection that triggered it may be: food poisoning bacteria can spread through poor hand hygiene and contaminated food, and chlamydia is passed on through sex. Getting tested and treated, and having partners treated, helps prevent re-infection.

When is a swollen joint after an infection an emergency?

A single hot, red, very painful swollen joint with fever, chills or feeling unwell needs same-day medical assessment. Septic (infected) arthritis can look like reactive arthritis and can destroy a joint within days; only testing fluid drawn from the joint can reliably tell them apart. Also seek urgent care for a painful red eye or blurred vision.

References

  1. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011;25(3):347–357. PubMed 22100285
  2. Schmitt SK. Reactive arthritis. Infect Dis Clin North Am. 2017;31(2):265–277. PubMed 28292540
  3. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am. 2009;35(1):21–44. PubMed 19480995
  4. Townes JM, Deodhar AA, Laine ES, et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann Rheum Dis. 2008;67(12):1689–1696. PubMed 18272671
  5. Ajene AN, Fischer Walker CL, Black RE. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, Salmonella and Shigella-associated reactive arthritis. J Health Popul Nutr. 2013;31(3):299–307. PubMed 24288942
  6. Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum. 2007;37(1):48–55. PubMed 17360026
  7. Hannu T, Mattila L, Rautelin H, et al. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford). 2002;41(3):312–318. PubMed 11934969
  8. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis. 2002;61(3):264–266. PubMed 11830436
  9. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis. 2005;64(4):594–598. PubMed 15550534
  10. Hannu T, Mattila L, Nuorti JP, et al. Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection. Ann Rheum Dis. 2003;62(9):866–869. PubMed 12922960
  11. Rich E, Hook EW 3rd, Alarcón GS, Moreland LW. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum. 1996;39(7):1172–1177. PubMed 8670327
  12. Birnbaum J, Bartlett JG, Gelber AC. Clostridium difficile: an under-recognized cause of reactive arthritis? Clin Rheumatol. 2008;27(2):253–255. PubMed 17902012
  13. Zeidler H, Hudson AP. Quo vadis reactive arthritis? Curr Opin Rheumatol. 2022;34(4):218–224. PubMed 35699331
  14. Zarpoosh M, Amirian P. COVID-associated arthritis after severe and non-severe COVID-19: a systematic review. Immun Inflamm Dis. 2023;11(10):e1035. PubMed 37904701
  15. Leirisalo-Repo M, Helenius P, Hannu T, et al. Long-term prognosis of reactive salmonella arthritis. Ann Rheum Dis. 1997;56(9):516–520. PubMed 9370874
  16. Wu IB, Schwartz RA. Reiter's syndrome: the classic triad and more. J Am Acad Dermatol. 2008;59(1):113–121. PubMed 18436339
  17. Wallace DJ, Weisman M. Should a war criminal be rewarded with eponymous distinction? The double life of Hans Reiter (1881–1969). J Clin Rheumatol. 2000;6(1):49–54. PubMed 19078450
  18. Panush RS, Wallace DJ, Dorff RE, Engleman EP. Retraction of the suggestion to use the term "Reiter's syndrome" sixty-five years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum. 2007;56(2):693–694. PubMed 17265506
  19. Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010;375(9717):846–855. PubMed 20206778
  20. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome): a Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 1996;39(12):2021–2027. PubMed 8961907
  21. Sieper J, Fendler C, Laitko S, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum. 1999;42(7):1386–1396. PubMed 10403266
  22. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. PubMed 34292926
  23. Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010;62(5):1298–1307. PubMed 20155838
  24. Garg AX, Pope JE, Thiessen-Philbrook H, et al. Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford). 2008;47(2):200–204. PubMed 18184664
  25. Reactive Arthritis — American College of Rheumatology, patient fact sheet (updated February 2025). rheumatology.org/patients/reactive-arthritis
  26. Reactive arthritis — NHS (UK), Health A to Z (reviewed December 2024). nhs.uk/conditions/reactive-arthritis
  27. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004;17(2):348–369. PubMed 15084505